detax is a specialist in medical polymer materials.
As a specialist in polymer chemistry, the detax Group offers its customers a comprehensive product portfolio in the dental and audio sectors. The 3D printing sector, in which detax has an excellent market position as a pioneer, is experiencing particularly dynamic development.
The Group serves an international, broadly diversified and loyal customer base. Users of the products include dental practices and dental laboratories as well as audiologists and laboratories. The Group operates in a non-cyclical and highly regulated market environment. detax already has all the relevant MDR certificates. This makes detax one of the first companies in the industry with comprehensive MDR certification.
A consortium of investors comprising PINOVA, ECM and Gilde Healthcare, together with the management, acquired the shares in detax in January 2022.
